We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.165 | -6.86% | 2.24 | 2.20 | 2.28 | 2.30 | 2.20 | 2.30 | 1,421,575 | 16:35:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.93 | 7.33M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/9/2022 13:50 | Quote possibly a pump and dump but someone definitely bought a lot by AT aggressively. They were poorly executed trades so can’t believe it was someone who is very experienced. | nobbygnome | |
06/9/2022 13:49 | Dnt see any news Doubt there has been any leakProb mms trying to dump stock so they orchestrate ways to get folks buying so they can dump stock | dillydally2 | |
06/9/2022 13:38 | 135k buy at 7.38😳 | nobbygnome | |
06/9/2022 13:36 | Pump n dump | dillydally2 | |
06/9/2022 13:32 | Coming off again now. Someone was aggressively trying to buy about 500k and paid 7p for some of it. Hmmmmm | nobbygnome | |
06/9/2022 13:26 | Thanks Ultimate.. Looking good now.. Honestly this has been nightmare so far and hope we all make decent on the upcoming P3 approval. 100% incoming I think | eva_1989 | |
06/9/2022 13:18 | Hmmm, over 300k bought by someone in the last few mins. Announcement from Avion this afternoon anyone?!? | nobbygnome | |
06/9/2022 13:11 | Price building today. There is currently 300k on the bid at 6.36 | nobbygnome | |
01/9/2022 13:47 | Dillydally is terminator who has multiple aliases and try to trade couple of percent.He did the same at eog recently.. | neo26 | |
31/8/2022 14:53 | Quite! No idea who dillydally2 was actually referring to. Anyhow, best ignore people who can't use civil language to make their point. | lord loads of lolly | |
31/8/2022 14:20 | It’s amazing how everybody seems to have their own trolls! So sad… | nobbygnome | |
31/8/2022 14:19 | dillydally2 - ignored. | lord loads of lolly | |
31/8/2022 13:40 | Look who it is | dillydally2 | |
31/8/2022 11:27 | The following has been posted on the LSE board: "Type C meetings should be scheduled to occur within 75 days of FDA receipt of the written meeting request." The poster then goes on to say: "This meeting request was sent in 27th June so the latest possible response date from the FDA is 12th September." I'm not saying this is correct though, as FDA delays could always override their normal timeframes I guess. | lord loads of lolly | |
31/8/2022 11:20 | Bu it should have been Monday so unless the FDA have given specific guidance of when to expect the response, it could come any day | nobbygnome | |
31/8/2022 11:17 | I thought they had just told you it won't be today due to FDA delays (which are rather common these days). The Company is in close contact with Avion and have been advised that the FDA is experiencing general delays in meeting response dates and that this is not specific to Avion and the Type C meeting for Lupuzor(TM) (P140). | waterloo01 | |
31/8/2022 10:57 | A few chunky buys coming in so there is a good chance of a turnaround in the price. I guess there is a chance Avion will hear today…. | nobbygnome | |
31/8/2022 10:45 | RNS this arvo when our brothers & sisters across the pond wake - approval ?? - 10p ? | naim96aim | |
31/8/2022 10:41 | OK - thanks Nobby. I know it was an impossible question really, so I don't think anyone will hold you to your answer! After all, nobody knows for sure. And we might never get there if the FDA has other thoughts. Fingers crossed though. | lord loads of lolly | |
31/8/2022 10:34 | Well you really are asking me to nail my colours to the mast which of course then opens me to ridicule from the normal suspects if it doesn’t come to pass. Nevertheless I will press on. I would expect a spike to around 10p but it will be temporary. We won’t get the phase III results probably until 2025 so any sustained rise in the short term depends on positive news from other parts of the portfolio including Lupuzor in other indications. | nobbygnome | |
31/8/2022 09:54 | Thanks nobby. Yes, I meant TRIAL approval. I know you feel drug dosage means it's doomed. Follow up question: based on other companies' share prices where trial approval was granted, what sort of impact would you expect this to have on IMM's share price (if trial approved). And would you anticipate an initial spike, followed by some floating back down. Or is it more likely the share price would steadily gain over the weeks following any trial approval announcement? I should really have asked you all this before jumping in again yesterday, but still interested to know your thoughts. | lord loads of lolly | |
31/8/2022 09:48 | I presume you mean grant approval of the trial going ahead. I would put that at 80:20 However the chance of the drug ever being approved for Lupus about 5:95…. | nobbygnome |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions